(Q68198887)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1626202%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1626202%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Patterns of Primary Care and Survival in 336 Consecutive Unselected Norwegian Patients With Bladder Cancer (English)

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

17 October 2022

1 reference

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

17 October 2022

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

17 October 2022

1

S D Fosså

1 reference

22 September 2019

S. Ous

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626202

17 October 2022

S. Espetveit

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626202

17 October 2022

F. Langmark

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626202

17 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1626202

17 October 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1626202%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://www.tandfonline.com/doi/pdf/10.1080/00365599.1992.11690444

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Scandinavian Journal of Urology and Nephrology

17 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1626202%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1626202%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1626202%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

131-138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1626202%20AND%20SRC:MED&resulttype=core&format=json

Neodymium-YAG laser irradiation of stage T2 muscle-invasive bladder cancer. Long-term results

22 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Survival rates of patients with bladder tumours. An experience of 1744 cases (1950-1978)

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Irradiation therapy with multiple small fractions per day in urinary bladder cancer

17 October 2022

4

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Clinical significance of the "palpable mass" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy.

17 October 2022

6

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Clinical significance of the "palpable mass" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy.

17 October 2022

7

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Radical irradiation of T2 and T3 bladder carcinoma. A retrospective investigation

17 October 2022

8

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Bladder cancer: staging with CT and MR imaging.

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values

17 October 2022

11

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up

17 October 2022

15

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Split-course radiotherapy of carcinoma of the urinary bladder stages C and D1. A Radiation Therapy Oncology Group Study

17 October 2022

16

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

The epidermal growth factor receptor and the prognosis of bladder cancer.

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Analysis of the performance of pathologists in the grading of bladder tumors.

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Bladder carcinoma as a systemic disease

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy

17 October 2022

20

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Adjuvant Chemotherapy with Doxorubicin (Adriamycin) and 5-Fluorouracil in T3, NX, MO Bladder Cancer Treated with Radiotherapy

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Contrast-Enhanced Computed Tomography in Carcinoma of the Urinary Bladder

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen

17 October 2022

24

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival

17 October 2022

25

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer

17 October 2022

26

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium

17 October 2022

27

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Carcinoma of the urinary bladder (category T1NxM0) treated either by radium implant or by transurethral resection only

17 October 2022

29

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder

17 October 2022

31

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease

17 October 2022

32

1 reference

https://api.crossref.org/works/10.1080/00365599.1992.11690444

17 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1626202%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference